BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 7130745)

  • 21. Photoprotection in vitiligo and normal skin. A quantitative assessment of the role of stratum corneum, viable epidermis and pigmentation.
    Gniadecka M; Wulf HC; Mortensen NN; Poulsen T
    Acta Derm Venereol; 1996 Nov; 76(6):429-32. PubMed ID: 8982403
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Vitiligo Skin: Exploring the Dermal Compartment.
    Kovacs D; Bastonini E; Ottaviani M; Cota C; Migliano E; Dell'Anna ML; Picardo M
    J Invest Dermatol; 2018 Feb; 138(2):394-404. PubMed ID: 29024688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Melanosomes, melanocytes and keratinocytes in the human epidermis in incontinentia pigmenti].
    Martinez G; Carnazza Marraro ML; Caltabiano C
    Arch Ital Anat Embriol; 1990; 95(1):65-76. PubMed ID: 2275600
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Preparation of mixed keratinocyte and melanocyte cultures from biopsy specimens of pigmented skin sites of patients with vitiligo.
    Usovetskii IA; Burunova VV; Kovtun NE; Suzdal'tseva YG; Krasil'nikova YB; Korotkii NG; Yarygin KN
    Bull Exp Biol Med; 2009 Jul; 148(1):103-5. PubMed ID: 19902109
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [In vitro culture of melanocyte-bearing epidermis and its application in the treatment of vitiligo and the stable leukodermas].
    Falabella R; Borrero I; Escobar C
    Med Cutan Ibero Lat Am; 1989; 17(3):193-8. PubMed ID: 2475729
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Keratinocyte dysfunction in vitiligo epidermis: cytokine microenvironment and correlation to keratinocyte apoptosis.
    Moretti S; Fabbri P; Baroni G; Berti S; Bani D; Berti E; Nassini R; Lotti T; Massi D
    Histol Histopathol; 2009 Jul; 24(7):849-57. PubMed ID: 19475531
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Long-term actinic damage in sun-exposed vitiligo and normally pigmented skin.
    Calanchini-Postizzi E; Frenk E
    Dermatologica; 1987; 174(6):266-71. PubMed ID: 3622877
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Reduced Nrf2 activation in PI3K phosphorylation-impaired vitiliginous keratinocytes increases susceptibility to ROS-generating chemical-induced apoptosis.
    Kim H; Park CS; Lee AY
    Environ Toxicol; 2017 Dec; 32(12):2481-2491. PubMed ID: 28836394
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Histopathologic features in vitiligo.
    Kim YC; Kim YJ; Kang HY; Sohn S; Lee ES
    Am J Dermatopathol; 2008 Apr; 30(2):112-6. PubMed ID: 18360112
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A case of halo nevus with effete melanocytes.
    Hashimoto K
    Acta Derm Venereol; 1975; 55(2):87-95. PubMed ID: 48323
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Vitiligo - The story from within: A transmission electron microscopic study before and after narrow-band ultraviolet B.
    Fawzy MM; El Maadawi ZM; Hegazy RA; El Fatah NS
    Ultrastruct Pathol; 2016; 40(5):265-75. PubMed ID: 27594347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Coexistence and relationship of antikeratinocyte and antimelanocyte antibodies in patients with non-segmental-type vitiligo.
    Yu HS; Kao CH; Yu CL
    J Invest Dermatol; 1993 Jun; 100(6):823-8. PubMed ID: 8496622
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pentachrome vitiligo.
    Fargnoli MC; Bolognia JL
    J Am Acad Dermatol; 1995 Nov; 33(5 Pt 2):853-6. PubMed ID: 7593796
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Transplantation of in vitro-cultured epidermis bearing melanocytes for repigmenting vitiligo.
    Falabella R; Escobar C; Borrero I
    J Am Acad Dermatol; 1989 Aug; 21(2 Pt 1):257-64. PubMed ID: 2768575
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Presence of T cells and macrophages in inflammatory vitiligo skin parallels melanocyte disappearance.
    Le Poole IC; van den Wijngaard RM; Westerhof W; Das PK
    Am J Pathol; 1996 Apr; 148(4):1219-28. PubMed ID: 8644862
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The treatment of vitiligo with topical corticosteroids. Light and electronmicroscopic studies.
    Bleehen SS
    Br J Dermatol; 1976 Mar; 94 suppl 12():43-50. PubMed ID: 773413
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Probable mechanisms of loss of Merkel cells in completely depigmented skin of stable vitiligo.
    Bose SK
    J Dermatol; 1994 Oct; 21(10):725-8. PubMed ID: 7798428
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.
    Wagner RY; Luciani F; Cario-André M; Rubod A; Petit V; Benzekri L; Ezzedine K; Lepreux S; Steingrimsson E; Taieb A; Gauthier Y; Larue L; Delmas V
    J Invest Dermatol; 2015 Jul; 135(7):1810-1819. PubMed ID: 25634357
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Hypomelanosis guttata idiopathica].
    Schiller M; Metze D; Böhm M
    Hautarzt; 1997 Sep; 48(9):662-5. PubMed ID: 9410853
    [TBL] [Abstract][Full Text] [Related]  

  • 40. PUVA-induced repigmentation of vitiligo: a histochemical (split-DOPA) and ultrastructural study.
    Ortonne JP; MacDonald DM; Micoud A; Thivolet J
    Br J Dermatol; 1979 Jul; 101(1):1-12. PubMed ID: 113025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.